APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral COVID-19 Antiviral Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral COVID-19 Antiviral Medicine Industry Growth and Trends Forecast to 2032

31 December 202571 pages

Choose your research edition.

Industry ResearchOral COVID-19 Antiviral Medicine Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral COVID-19 Antiviral Medicine Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Oral COVID-19 Antiviral Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral COVID-19 Antiviral Medicine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral COVID-19 Antiviral Medicine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Oral COVID-19 Antiviral Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral COVID-19 Antiviral Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral COVID-19 Antiviral Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral COVID-19 Antiviral Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral COVID-19 Antiviral Medicine include Merck and Ridgeback. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral COVID-19 Antiviral Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral COVID-19 Antiviral Medicine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral COVID-19 Antiviral Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral COVID-19 Antiviral Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral COVID-19 Antiviral Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral COVID-19 Antiviral Medicine Market by Company

Merck and Ridgeback

Oral COVID-19 Antiviral Medicine Segment by Type

Tablet

Capsule

Oral COVID-19 Antiviral Medicine Segment by Application

Hospital

Clinic

Oral COVID-19 Antiviral Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral COVID-19 Antiviral Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral COVID-19 Antiviral Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral COVID-19 Antiviral Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral COVID-19 Antiviral Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral COVID-19 Antiviral Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Capsule Table 3. Global Oral COVID-19 Antiviral Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units) Table 5. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Type (2021-2026) Table 8. Global Oral COVID-19 Antiviral Medicine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Oral COVID-19 Antiviral Medicine Sales by Type (2027-2032) & (K Units) Table 10. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oral COVID-19 Antiviral Medicine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Type (2027-2032) Table 13. Global Oral COVID-19 Antiviral Medicine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units) Table 15. North America Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units) Table 17. Europe Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales by Type (2021-2026) & (US$ Million) Table 24. Oral COVID-19 Antiviral Medicine Industry Trends Table 25. Oral COVID-19 Antiviral Medicine Industry Drivers Table 26. Oral COVID-19 Antiviral Medicine Industry Opportunities and Challenges Table 27. Oral COVID-19 Antiviral Medicine Industry Restraints Table 28. Global Oral COVID-19 Antiviral Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oral COVID-19 Antiviral Medicine Revenue Market Share by Company (2021-2026) Table 30. Global Oral COVID-19 Antiviral Medicine Sales by Company (2021-2026) & (K Units) Table 31. Global Oral COVID-19 Antiviral Medicine Sales Share by Company (2021-2026) Table 32. Global Oral COVID-19 Antiviral Medicine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Oral COVID-19 Antiviral Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oral COVID-19 Antiviral Medicine Major Company Production Sites and Headquarters Table 35. Global Oral COVID-19 Antiviral Medicine Company, Product Type & Application Table 36. Global Oral COVID-19 Antiviral Medicine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oral COVID-19 Antiviral Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oral COVID-19 Antiviral Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oral COVID-19 Antiviral Medicine Sales by Region (2021-2026) & (K Units) Table 41. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oral COVID-19 Antiviral Medicine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Region (2021-2026) Table 44. Global Oral COVID-19 Antiviral Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Oral COVID-19 Antiviral Medicine Sales by Region (2027-2032) & (K Units) Table 46. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oral COVID-19 Antiviral Medicine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Region (2027-2032) Table 49. Global Oral COVID-19 Antiviral Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Oral COVID-19 Antiviral Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units) Table 52. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Application (2021-2026) Table 55. Global Oral COVID-19 Antiviral Medicine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Oral COVID-19 Antiviral Medicine Sales by Application (2027-2032) & (K Units) Table 57. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oral COVID-19 Antiviral Medicine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Application (2027-2032) Table 60. Global Oral COVID-19 Antiviral Medicine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units) Table 62. North America Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units) Table 64. Europe Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales by Application (2021-2026) & (US$ Million) Table 71. Merck and Ridgeback Company Information Table 72. Merck and Ridgeback Business Overview Table 73. Merck and Ridgeback Oral COVID-19 Antiviral Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck and Ridgeback Oral COVID-19 Antiviral Medicine Product Portfolio Table 75. Merck and Ridgeback Recent Development Table 76. North America Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 77. North America Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026) & (K Units) Table 78. North America Oral COVID-19 Antiviral Medicine Sales Market Share by Country (2021-2026) Table 79. North America Oral COVID-19 Antiviral Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 80. North America Oral COVID-19 Antiviral Medicine Sales Market Share Forecast by Country (2027-2032) Table 81. North America Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 82. North America Oral COVID-19 Antiviral Medicine Market Size by Country (2021-2026) & (US$ Million) Table 83. North America Oral COVID-19 Antiviral Medicine Market Share by Country (2021-2026) Table 84. North America Oral COVID-19 Antiviral Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 85. North America Oral COVID-19 Antiviral Medicine Market Share Forecast by Country (2027-2032) Table 86. Europe Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. Europe Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026) & (K Units) Table 88. Europe Oral COVID-19 Antiviral Medicine Sales Market Share by Country (2021-2026) Table 89. Europe Oral COVID-19 Antiviral Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 90. Europe Oral COVID-19 Antiviral Medicine Sales Market Share Forecast by Country (2027-2032) Table 91. Europe Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. Europe Oral COVID-19 Antiviral Medicine Market Size by Country (2021-2026) & (US$ Million) Table 93. Europe Oral COVID-19 Antiviral Medicine Market Share by Country (2021-2026) Table 94. Europe Oral COVID-19 Antiviral Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. Europe Oral COVID-19 Antiviral Medicine Market Share Forecast by Country (2027-2032) Table 96. Asia-Pacific Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026) & (K Units) Table 98. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Market Share by Country (2021-2026) Table 99. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 100. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Oral COVID-19 Antiviral Medicine Market Size by Country (2021-2026) & (US$ Million) Table 103. Asia-Pacific Oral COVID-19 Antiviral Medicine Market Share by Country (2021-2026) Table 104. Asia-Pacific Oral COVID-19 Antiviral Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Asia-Pacific Oral COVID-19 Antiviral Medicine Market Share Forecast by Country (2027-2032) Table 106. Latin America Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Latin America Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026) & (K Units) Table 108. Latin America Oral COVID-19 Antiviral Medicine Sales Market Share by Country (2021-2026) Table 109. Latin America Oral COVID-19 Antiviral Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 110. Latin America Oral COVID-19 Antiviral Medicine Sales Market Share Forecast by Country (2027-2032) Table 111. Latin America Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Latin America Oral COVID-19 Antiviral Medicine Market Size by Country (2021-2026) & (US$ Million) Table 113. Latin America Oral COVID-19 Antiviral Medicine Market Share by Country (2021-2026) Table 114. Latin America Oral COVID-19 Antiviral Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Latin America Oral COVID-19 Antiviral Medicine Market Share Forecast by Country (2027-2032) Table 116. Middle East and Africa Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026) & (K Units) Table 118. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Market Share by Country (2021-2026) Table 119. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Oral COVID-19 Antiviral Medicine Market Size by Country (2021-2026) & (US$ Million) Table 123. Middle East and Africa Oral COVID-19 Antiviral Medicine Market Share by Country (2021-2026) Table 124. Middle East and Africa Oral COVID-19 Antiviral Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Middle East and Africa Oral COVID-19 Antiviral Medicine Market Share Forecast by Country (2027-2032) Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Oral COVID-19 Antiviral Medicine Distributors List Table 129. Oral COVID-19 Antiviral Medicine Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Oral COVID-19 Antiviral Medicine Image Figure 2. Global Oral COVID-19 Antiviral Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral COVID-19 Antiviral Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral COVID-19 Antiviral Medicine Sales (2021-2032) & (K Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsule Image Figure 8. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Oral COVID-19 Antiviral Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oral COVID-19 Antiviral Medicine Market Share by Type 2025 VS 2032 Figure 11. North America Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Type in 2025 Figure 12. North America Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Type in 2025 Figure 13. Europe Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oral COVID-19 Antiviral Medicine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Oral COVID-19 Antiviral Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Oral COVID-19 Antiviral Medicine Market Share by Application 2025 VS 2032 Figure 29. North America Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Application in 2025 Figure 30. North America Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Application in 2025 Figure 31. Europe Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Market Share in Value by Application in 2025 Figure 39. North America Oral COVID-19 Antiviral Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Oral COVID-19 Antiviral Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Oral COVID-19 Antiviral Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Oral COVID-19 Antiviral Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Oral COVID-19 Antiviral Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Oral COVID-19 Antiviral Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oral COVID-19 Antiviral Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Oral COVID-19 Antiviral Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oral COVID-19 Antiviral Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Oral COVID-19 Antiviral Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Oral COVID-19 Antiviral Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Oral COVID-19 Antiviral Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oral COVID-19 Antiviral Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Oral COVID-19 Antiviral Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oral COVID-19 Antiviral Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Oral COVID-19 Antiviral Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Oral COVID-19 Antiviral Medicine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Oral COVID-19 Antiviral Medicine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Hospital
  • Clinic
Companies covered
  • Merck and Ridgeback

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral COVID-19 Antiviral Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral COVID-19 Antiviral Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral COVID-19 Antiviral Medicine Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Capsule
  8. 1.4 Global Oral COVID-19 Antiviral Medicine Market Size by Type
  9. 1.4.1 Global Oral COVID-19 Antiviral Medicine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oral COVID-19 Antiviral Medicine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oral COVID-19 Antiviral Medicine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oral COVID-19 Antiviral Medicine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oral COVID-19 Antiviral Medicine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oral COVID-19 Antiviral Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral COVID-19 Antiviral Medicine Industry Trends
  2. 2.2 Oral COVID-19 Antiviral Medicine Industry Drivers
  3. 2.3 Oral COVID-19 Antiviral Medicine Industry Opportunities and Challenges
  4. 2.4 Oral COVID-19 Antiviral Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral COVID-19 Antiviral Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral COVID-19 Antiviral Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Oral COVID-19 Antiviral Medicine Price (2021-2026)
  4. 3.4 Global Oral COVID-19 Antiviral Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral COVID-19 Antiviral Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Oral COVID-19 Antiviral Medicine Company, Product Type & Application
  7. 3.7 Global Oral COVID-19 Antiviral Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral COVID-19 Antiviral Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral COVID-19 Antiviral Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral COVID-19 Antiviral Medicine Tier 1, Tier 2, and Tier 3
4 Oral COVID-19 Antiviral Medicine Regional Status and Outlook
  1. 4.1 Global Oral COVID-19 Antiviral Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral COVID-19 Antiviral Medicine Historic Market Size by Region
  3. 4.2.1 Global Oral COVID-19 Antiviral Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral COVID-19 Antiviral Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral COVID-19 Antiviral Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral COVID-19 Antiviral Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Oral COVID-19 Antiviral Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral COVID-19 Antiviral Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral COVID-19 Antiviral Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral COVID-19 Antiviral Medicine by Application
  1. 5.1 Oral COVID-19 Antiviral Medicine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Oral COVID-19 Antiviral Medicine Market Size by Application
  5. 5.2.1 Global Oral COVID-19 Antiviral Medicine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oral COVID-19 Antiviral Medicine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oral COVID-19 Antiviral Medicine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oral COVID-19 Antiviral Medicine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oral COVID-19 Antiviral Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oral COVID-19 Antiviral Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck and Ridgeback
  2. 6.1.1 Merck and Ridgeback Company Information
  3. 6.1.2 Merck and Ridgeback Business Overview
  4. 6.1.3 Merck and Ridgeback Oral COVID-19 Antiviral Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck and Ridgeback Oral COVID-19 Antiviral Medicine Product Portfolio
  6. 6.1.5 Merck and Ridgeback Recent Developments
7 North America by Country
  1. 7.1 North America Oral COVID-19 Antiviral Medicine Sales by Country
  2. 7.1.1 North America Oral COVID-19 Antiviral Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Oral COVID-19 Antiviral Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral COVID-19 Antiviral Medicine Market Size by Country
  6. 7.2.1 North America Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral COVID-19 Antiviral Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral COVID-19 Antiviral Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral COVID-19 Antiviral Medicine Sales by Country
  2. 8.1.1 Europe Oral COVID-19 Antiviral Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral COVID-19 Antiviral Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral COVID-19 Antiviral Medicine Market Size by Country
  6. 8.2.1 Europe Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral COVID-19 Antiviral Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral COVID-19 Antiviral Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral COVID-19 Antiviral Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral COVID-19 Antiviral Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral COVID-19 Antiviral Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral COVID-19 Antiviral Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral COVID-19 Antiviral Medicine Sales by Country
  2. 10.1.1 South America Oral COVID-19 Antiviral Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Oral COVID-19 Antiviral Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral COVID-19 Antiviral Medicine Market Size by Country
  6. 10.2.1 South America Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral COVID-19 Antiviral Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral COVID-19 Antiviral Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral COVID-19 Antiviral Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral COVID-19 Antiviral Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral COVID-19 Antiviral Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral COVID-19 Antiviral Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Oral COVID-19 Antiviral Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral COVID-19 Antiviral Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral COVID-19 Antiviral Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral COVID-19 Antiviral Medicine Value Chain Analysis
  2. 12.1.1 Oral COVID-19 Antiviral Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral COVID-19 Antiviral Medicine Production Mode & Process
  7. 12.2 Oral COVID-19 Antiviral Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral COVID-19 Antiviral Medicine Distributors
  10. 12.2.3 Oral COVID-19 Antiviral Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst